SecurityAMID / American Midstream Partners LP (02752P100)
Institutional Owners93 (28 N-Q Owners)
Institutional Shares33,403,931 - 63.40% (ex. N-Q)
Common Shares Outstanding52,684,359 shares (as of 2017-09-30)
Institutional Value$ 406,185,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

American Midstream Partners LP (NYSE:AMID) has 93 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 33,403,931 shares. Largest shareholders include ArcLight Capital Partners, LLC, Oppenheimer Funds Inc, Swank Capital, LLC, Cushing Asset Management, Lp, Advisory Research Inc, HITE Hedge Asset Management LLC, Bank Of America Corp /de/, Neuberger Berman Group LLC, Price Michael F, and UBS Group AG.

American Midstream Partners LP (NYSE:AMID) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-09 13F-HR Crewe Advisors Llc 866 12
2017-11-08 13F-HR NEXT Financial Group, Inc 5,800 0 -100.00 75,000 0 -100.00
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 36,446 39,905 9.49 497 532 7.04
2018-02-08 13F-HR ADVISORY RESEARCH INC 1,317,169 1,637,219 24.30 17,979 21,857 21.57
2018-02-15 13F-HR YORKVILLE CAPITAL MANAGEMENT, LLC 34,129 0 -100.00 466 0 -100.00
2018-02-14 13F-HR ROYAL BANK OF CANADA 39,958 32,449 -18.79 545 433 -20.55
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 57,750 57,750 0.00 788 771 -2.16
2018-02-08 13F-HR Global X Management CO LLC 780 0 -100.00 11 0 -100.00
2017-10-26 N-Q Clearbridge Energy Mlp Opportunity Fund Inc. (see advisory)
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 9,224 0 -100.00 126 0 -100.00
2018-02-14 13F-HR CUSHING ASSET MANAGEMENT, LP 2,418,887 2,379,267 -1.64 33,018 31,763 -3.80
2018-02-14 13F-HR Neuberger Berman Group LLC 793,275 703,275 -11.35 10,828 9,389 -13.29
2018-02-14 13F-HR PEAK6 Investments, L.P. 12,461 10,478 -15.91 170 140 -17.65
2017-11-06 13F-HR Spot Trading L.l.c. Call 15,500 0 -100.00 199 0 -100.00
2018-02-14 13F-HR Advisor Group, Inc. 5,378 5,078 -5.58 74 67 -9.46
2018-02-13 13F-HR Mosaic Family Wealth, LLC 2,800 2,800 0.00 38 37 -2.63
2018-02-28 N-Q Rydex Series Funds (see advisory)
2018-02-14 13F-HR TORTOISE INDEX SOLUTIONS, LLC 332 4,879 1,369.58 4 65 1,525.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 218 143 -34.40 32 26 -18.75
2017-10-30 N-Q Fiduciary/claymore Mlp Opportunity Fund (see advisory)
2017-10-25 N-Q Clearbridge American Energy Mlp Fund Inc. (see advisory)
2018-02-14 13F-HR WOLVERINE TRADING, LLC Call 0 23,200 0 310
2018-02-12 13F-HR EAGLE GLOBAL ADVISORS LLC 10,000 0 -100.00 136 0 -100.00
2018-02-14 13F-HR COHEN & STEERS INC 235,279 235,369 0.04 3,212 3,142 -2.18
2018-02-12 13F-HR Arrow Investment Advisors, LLC 61,044 53,644 -12.12 833 716 -14.05
2018-02-12 13F-HR CITIGROUP INC 34,622 6,291 -81.83 473 84 -82.24
2018-02-09 13F-HR CITADEL ADVISORS LLC Call 18,700 37,300 99.47 255 498 95.29
2018-02-13 13F-HR Intellectus Partners, LLC 1,392 1,435 3.09 19 19 0.00
2018-04-20 13F-HR Seacrest Wealth Management, Llc 600 600 0.00 8 6 -25.00
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 150,300 98,600 -34.40 2,052 1,316 -35.87
2017-11-07 13F-HR Sumitomo Mitsui Trust Holdings, Inc. 19,000 0 -100.00 244 0 -100.00
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,423 58,105 159.13 306 776 153.59
2018-01-17 13F-HR Cutler Group LP Call 300 0 -100.00 0 0
2018-04-11 13F-HR LifePlan Financial Group, Inc 4,950 53
2017-10-30 N-Q Nuveen Energy Mlp Total Return Fund (see advisory)
2018-02-21 13F-HR Penbrook Management LLC 66,700 890
2018-01-17 13F-HR Cutler Group LP 11,623 723 -93.78 158 9 -94.30
2018-02-28 N-Q American High Income Trust (see advisory)
2018-02-14 13F-HR FIFTH THIRD BANCORP 5,751 77
2018-02-14 13F-HR DEUTSCHE BANK AG\ 239,495 4 -100.00 3,556 0 -100.00
2017-10-23 N-Q Cohen & Steers Mlp Income & Energy Opportunity Fund (see advisory)
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 2,393 2,349 -1.84 33 31 -6.06
2017-10-27 N-Q Virtus Total Return Fund Inc. (see advisory)
2018-02-06 SC 13G/A OPPENHEIMER FUNDS INC 5,798,609 6,087,090 4.98
2017-11-06 13F-HR Spot Trading L.l.c. 6,807 18,259 168.24 87 249 186.21
2018-02-09 13F-HR CITADEL ADVISORS LLC Put 12,600 26,600 111.11 172 355 106.40
2017-10-26 N-Q Global X Funds (see advisory)
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 28,370 28,373 0.01 379 306 -19.26
2018-01-26 13F-HR Regent Investment Management LLC 11,756 12,756 8.51 160 170 6.25
2018-02-13 13F-HR PRICE MICHAEL F 685,499 685,499 0.00 9,357 9,152 -2.19
2017-10-30 N-Q Oppenheimer Steelpath Mlp Funds Trust (see advisory)
2017-10-26 N-Q Spirit Of America Investment Fund Inc (see advisory)
2018-02-06 13F-HR Sunbelt Securities, Inc. 10,750 10,750 0.00 147 144 -2.04
2018-02-09 13F-HR ELCO Management Co., LLC 225,180 226,755 0.70 3,074 3,027 -1.53
2018-02-14 13F-HR UBS Group AG 738,869 675,434 -8.59 10,086 9,017 -10.60
2018-04-12 13F-HR STARR INTERNATIONAL CO INC 100,000 100,000 0.00 1,335 1,080 -19.10
2017-10-30 N-Q Managed Portfolio Series (see advisory)
2018-02-14 13F-HR PEAK6 Investments, L.P. Put 88,400 54,200 -38.69 1,207 724 -40.02
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 79,636 70,290 -11.74 1,087 938 -13.71
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 0 17,850 0 239
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 25,000 25,000 0.00 334 270 -19.16
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 5,572 5,572 0.00 76,058 74,386 -2.20
2018-02-28 N-Q Virtus Equity Trust (see advisory)
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 761,352 748,410 -1.70 10,392 9,991 -3.86
2018-02-14 13F-HR Intrinsic Edge Capital Management LLC 113,404 1,514
2018-02-14 13F-HR HITE Hedge Asset Management LLC 740,756 889,008 20.01 10,111 11,868 17.38
2018-02-14 13F-HR PEAK6 Investments, L.P. Call 26,700 11,100 -58.43 364 148 -59.34
2018-02-14 13F-HR Clearbridge Investments, LLC 388,888 388,888 0.00 5,308 5,192 -2.19
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 13,750 13,548 -1.47 187 181 -3.21
2018-02-07 13F-HR Texas Yale Capital Corp. 13,100 13,100 0.00 179 175 -2.23
2018-01-10 13F-HR SIMPLEX TRADING, LLC 13,885 18,717 34.80 189 249 31.75
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 31,300 9,600 -69.33 427 128 -70.02
2018-02-09 13F-HR Virtu Financial LLC 15,171 203
2018-02-13 13F-HR Cannell Peter B & Co Inc 34,300 458
2018-03-01 N-Q Calvert Fund (see advisory)
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 3 28 833.33 0 0
2018-02-14 13F-HR Rafferty Asset Management, LLC 200,636 174,644 -12.95 2,739 2,331 -14.90
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 100 100 0.00 1 1 0.00
2017-12-29 N-Q Arrow Etf Trust (see advisory)
2018-02-02 13F-HR Center Coast Capital Advisors, LP 30,000 401
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 75,800 15,800 -79.16 1,035 211 -79.61
2018-02-14 13F-HR WOLVERINE TRADING, LLC 19,797 0 -100.00 270 0 -100.00
2018-02-14 13F-HR MORGAN STANLEY 515,867 464,862 -9.89 7,040 6,205 -11.86
2018-02-27 N-Q Buffalo Funds (see advisory)
2017-10-30 N-Q Nuveen All Cap Energy Mlp Opportunities Fund (see advisory)
2018-01-24 13F-HR IFP Advisors, Inc 206 212 2.91 3 3 0.00
2017-10-25 N-Q Mainstay Funds Trust (see advisory)
2018-01-17 13F-HR Cutler Group LP Put 19,200 9,500 -50.52 51 14 -72.55
2018-02-14 13F-HR ArcLight Capital Partners, LLC 13,977,709 13,977,709 0.00 190,796 186,602 -2.20
2017-10-24 N-Q Cushing Energy Income Fund (see advisory)
2017-11-06 13F-HR TORONTO DOMINION BANK 2,035 0 -100.00 26 0 -100.00
2018-02-14 13F-HR Zions Bancorporation 6,871 6,871 0.00 94 92 -2.13
2018-02-14 13F-HR BROOKFIELD ASSET MANAGEMENT INC. 30,000 401
2018-03-01 N-Q City National Rochdale Funds (see advisory)
2018-02-27 N-Q Blackstone Alternative Investment Funds (see advisory)
2018-02-28 N-Q Sunamerica Income Funds (see advisory)
2018-02-08 13F-HR Global Financial Private Capital, LLC 20,600 20,600 0.00 281 275 -2.14
2017-11-06 13F-HR Spot Trading L.l.c. Put 32,900 31,500 -4.26 423 430 1.65
2017-10-20 N-Q Neuberger Berman Mlp Income Fund Inc. (see advisory)
2017-11-29 N-Q Virtus Variable Insurance Trust (see advisory)
2018-04-17 13F-HR SPIRIT OF AMERICA MANAGEMENT CORP/NY 250,929 250,929 0.00 3,350 2,710 -19.10
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 59,486 59,199 -0.48 812 790 -2.71
2018-02-14 SC 13G/A Swank Capital, LLC 2,557,100 2,379,267 -6.95
2017-12-29 N-Q Virtus Etf Trust Ii (see advisory)
2018-02-28 N-Q Virtus Opportunities Trust (see advisory)
2017-10-27 N-Q Virtus Global Multi-sector Income Fund (see advisory)
2018-02-14 13F-HR BARCLAYS PLC 10,163 11,198 10.18 138 149 7.97
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 11,400 11,700 2.63 156 156 0.00
2018-02-14 13F-HR Summit Trail Advisors, Llc 104 2
2018-01-30 13F-HR SECURITY NATIONAL TRUST CO 3,000 0 -100.00 41 0 -100.00
2018-02-12 13F-HR Atlantic Trust Group, LLC 814,037 437,893 -46.21 11,112 5,846 -47.39
2018-02-13 13F-HR JP Morgan Chase & Co 55 55 0.00 1 1 0.00
2018-02-01 13F-HR WESBANCO BANK INC 10,000 134
2018-02-09 13F-HR CITADEL ADVISORS LLC 0 42,227 0 564
2018-02-28 N-Q Morgan Stanley Institutional Fund Trust (see advisory)
2018-02-14 13F-HR WOLVERINE TRADING, LLC Put 37,100 23,600 -36.39 506 315 -37.75

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( AMID / American Midstream Partners LP ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 02752P100